People · Operator
Named in public records as an officer, director or promoter · active 2012–2022 · Biotechnology, Other Health Care, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| eyeBrain Medical, Inc. | — | Biotechnology | Series C | $126.3M | $1.2B | 2014 |
| RxSight, Inc. | — | Other Health Care | Series C | $76.4M | $1.1B | 2017 |
| Stroma Medical Corp | — | Healthtech | Series B | $43.0M | $767.6M | 2012 |
| Surface Ophthalmics, Inc. | — | Other Health Care | Series B | $40.1M | $422.4M | 2021 |
| Equinox, Inc. | — | Biotechnology | Series A | $34.7M | $485.2M | 2016 |
J. Andy Corley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside J. Andy Corley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| William Link | 2 | 11 |
| J Andrew Corley | 2 | 2 |
| Richard Lindstrom | 1 | 13 |
| Juliet Bakker | 1 | 9 |
| Richard L Lindstrom | 1 | 8 |
| Bruce Robertson | 1 | 7 |
| Eric Bednarski | 1 | 7 |
| Jack Kavanaugh | 1 | 6 |
| Steve Kirby | 1 | 6 |
| Mark Baum | 1 | 4 |
| John Berdahl | 1 | 3 |
| Tom Frinzi | 1 | 3 |
| Shelley Thunen | 1 | 3 |
| Matthew Larson | 1 | 3 |
| Steve T Kirby | 1 | 3 |
| Daniel M. Schwartz | 1 | 2 |
| AFSHIN NADERSHAHI | 1 | 2 |
| D. Verne Sharma | 1 | 2 |
| John Maynard | 1 | 2 |
| Werner F. Wolfen | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.